{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:13:51Z","timestamp":1758046431392,"version":"3.44.0"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The incidence of substance use disorder (SUD) during pregnancy continues to increase; however, the identification of SUD is challenging. The significance of individual risk factors and their association with toxicology is contentious. To identify maternal and neonatal risk factors associated with positive toxicology results for nonprescribed substance use during pregnancy.<\/jats:p><jats:p>This retrospective study included pregnant persons and their infants, who were screened for predetermined risk factors for SUD during pregnancy. The toxicology test results of pregnant persons' urine and infants' urine, meconium\/umbilical cord were correlated with risk factors.<\/jats:p><jats:p>Maternal risk factors (history of prepregnancy or current SUD, on medication for opioid use disorders, insufficient prenatal care, sexually transmitted and blood-borne infections) and neonatal risk factors (neonatal opioid withdrawal syndrome, intrauterine growth restriction) showed a correlation with toxicology results.<\/jats:p><jats:p>Combining maternal and neonatal risk factors with toxicology testing may accurately identify SUD in pregnancy.<\/jats:p>","DOI":"10.1055\/a-2535-5895","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T19:04:33Z","timestamp":1739214273000},"page":"1763-1770","source":"Crossref","is-referenced-by-count":0,"title":["Maternal and Neonatal Risk Factors Associated with Positive Toxicology Results"],"prefix":"10.1055","volume":"42","author":[{"given":"Hannah","family":"Pee","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hussein","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York"},{"name":"Department of Pediatrics, New York Medical College, Valhalla, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Del Savio","sequence":"additional","affiliation":[{"name":"Chief Medical Officer, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-0017","authenticated-orcid":false,"given":"Prabhakar","family":"Kocherlakota","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Regional Neonatal Intensive Care Unit, Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York"},{"name":"Department of Pediatrics, New York Medical College, Valhalla, New York"},{"name":"Department of Pediatrics, Elaine Kaplan NICU, Montefiore St. Luke's Cornwall Hospital, Newburgh, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"S 01","key":"ref1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10995-023-03670-z","article-title":"Prenatal substance exposure and neonatal abstinence syndrome: state estimates from the 2016-2020 transformed Medicaid statistical information system","volume":"27","author":"K D West","year":"2023","journal-title":"Matern Child Health J"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"e20182058","DOI":"10.1542\/peds.2018-3664","article-title":"Neonatal abstinence syndrome and associated neonatal and maternal mortality and morbidity","volume":"144","author":"S Lisonkova","year":"2019","journal-title":"Pediatrics"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"P Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.AOG.0000466371.86393.9b","article-title":"Committee opinion no. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10550887.2020.1831137","article-title":"Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy","volume":"39","author":"E Gonz\u00e1lez-Colmenero","year":"2021","journal-title":"J Addict Dis"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10995-015-1799-6","article-title":"Validity of self-reported drug use information among pregnant women","volume":"20","author":"M Garg","year":"2016","journal-title":"Matern Child Health J"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.whi.2016.12.008","volume":"27","year":"2017","journal-title":"Womens Health Issues"},{"issue":"05","key":"ref9","doi-asserted-by":"crossref","first-page":"100419","DOI":"10.1016\/j.ajogmf.2021.100419","article-title":"Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018","volume":"3","author":"E Patel","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/AOG.0000000000003230","article-title":"Accuracy of three screening tools for prenatal substance use","volume":"133","author":"V H Coleman-Cowger","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s10995-021-03127-1","article-title":"Improved maternal and infant outcomes with serial, self-reported early prenatal substance use screening","volume":"25","author":"S L Boden","year":"2021","journal-title":"Matern Child Health J"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/ADM.0000000000000614","article-title":"Validation of the NIDA-modified ASSIST as a screening tool for prenatal drug use in an urban setting in the United States","volume":"14","author":"E A Oga","year":"2020","journal-title":"J Addict Med"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.chc.2016.02.005","article-title":"Objective testing","volume":"25","author":"S E Hadland","year":"2016","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41372-022-01335-3","article-title":"Rates of substance and polysubstance use through universal maternal testing at the time of delivery","volume":"42","author":"B L Smith","year":"2022","journal-title":"J Perinatol"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"e2020029074","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"S W Patrick","year":"2020","journal-title":"Pediatrics"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jogn.2022.10.002","article-title":"Drug testing practices and policies of labor and delivery units across the Southeastern United States","volume":"52","author":"D P Byrd","year":"2023","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"08","key":"ref17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1542\/hpeds.2018-0256","article-title":"Risk-based newborn drug testing in a setting with a low prevalence of maternal drug use","volume":"9","author":"K E Wood","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11414-011-9247-x","article-title":"Universal screening for alcohol and drug use and racial disparities in child protective services reporting","volume":"39","author":"S CM Roberts","year":"2012","journal-title":"J Behav Health Serv Res"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"e20164070","DOI":"10.1542\/peds.2016-4070","article-title":"AAP Committee on Substance Use and Prevention. A public health response to opioid use in pregnancy","volume":"139","author":"S W Patrick","year":"2017","journal-title":"Pediatrics"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/AOG.0000000000005385","article-title":"Racial inequities in drug tests ordered by clinicians for pregnant people who disclose prenatal substance use","volume":"142","author":"A Olaniyan","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.acap.2016.10.003","article-title":"Wide variation found in care of opioid-exposed newborns","volume":"17","author":"D L Bogen","year":"2017","journal-title":"Acad Pediatr"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"M L Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"100453","DOI":"10.1016\/j.ajogmf.2021.100453","article-title":"Racial differences in indications for obstetrical toxicology testing and relationship of indications to test results","volume":"4","author":"N C Perlman","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"08","key":"ref24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41372-022-01457-8","article-title":"Neonatal abstinence syndrome: effectiveness of targeted umbilical cord drug screening","volume":"42","author":"A J Karr","year":"2022","journal-title":"J Perinatol"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.05.010","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (replaces Clinical Guideline Number 3, April 2012)","volume":"223","author":"J G Martins","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clinbiochem.2016.11.026","article-title":"Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: a retrospective study at an academic medical center","volume":"50","author":"K L Palmer","year":"2017","journal-title":"Clin Biochem"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"S L Wabuyele","year":"2018","journal-title":"Ther Drug Monit"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cll.2012.06.008","article-title":"Drug testing in the neonate","volume":"32","author":"S W Cotten","year":"2012","journal-title":"Clin Lab Med"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2393-14-250","article-title":"Retrospective analysis of the diagnostic yield of newborn drug testing","volume":"14","author":"K E Wood","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.whi.2011.03.001","article-title":"Predictors of prenatal and postpartum care adequacy in a Medicaid managed care population","volume":"21","author":"S Weir","year":"2011","journal-title":"Womens Health Issues"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10995-016-2190-y","article-title":"The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts","volume":"21","author":"M Kotelchuck","year":"2017","journal-title":"Matern Child Health J"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"e0189900","DOI":"10.1371\/journal.pone.0189900","article-title":"Racism and health service utilisation: a systematic review and meta-analysis","volume":"12","author":"J Ben","year":"2017","journal-title":"PLoS One"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1353\/hpu.2007.0059","article-title":"Determinants of inadequate prenatal care utilization by African American women","volume":"18","author":"A A Johnson","year":"2007","journal-title":"J Health Care Poor Underserved"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/eurpub\/ckad078","article-title":"Association between language barrier and inadequate prenatal care utilization among migrant women in the PreCARE prospective cohort study","volume":"33","author":"M Eslier","year":"2023","journal-title":"Eur J Public Health"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/j.semperi.2017.04.008","article-title":"Exploring the social determinants of racial\/ethnic disparities in prenatal care utilization and maternal outcome","volume":"41","author":"A Gadson","year":"2017","journal-title":"Semin Perinatol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"2211706","DOI":"10.1080\/14767058.2023.2211706","article-title":"Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?","volume":"36","author":"H Gersch","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"07","key":"ref37","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.ajogmf.2023.100963","article-title":"Assessing the clinical utility of toxicology testing in the peripartum period","volume":"5","author":"M R Siegel","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ADM.0000000000001230","article-title":"Agreement between self-reports and urine toxicology measures of illicit methamphetamine and cocaine use during early pregnancy","volume":"18","author":"A C Sujan","year":"2024","journal-title":"J Addict Med"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/ADM.0000000000000521","article-title":"The association between antenatal maternal self-reported substance use, maternal characteristics, and obstetrical variables","volume":"13","author":"A Berra","year":"2019","journal-title":"J Addict Med"},{"issue":"08","key":"ref40","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.2017.303825","article-title":"Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons","volume":"107","author":"M Jarlenski","year":"2017","journal-title":"Am J Public Health"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"e064118","DOI":"10.1136\/bmjopen-2022-064118","article-title":"Impact of COVID-19 on pregnancy-related healthcare utilisation: a prospective nationwide registry study","volume":"12","author":"C M Baravelli","year":"2022","journal-title":"BMJ Open"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41372-023-01613-8","article-title":"Comparing maternal substance use and perinatal outcomes before and during the COVID-19 pandemic","volume":"43","author":"J Lien","year":"2023","journal-title":"J Perinatol"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2535-5895.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:23:47Z","timestamp":1757719427000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2535-5895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":41,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,9,12]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2535-5895","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"type":"print","value":"0735-1631"},{"type":"electronic","value":"1098-8785"}],"subject":[],"published-other":{"date-parts":[[2025,2,10]]},"published":{"date-parts":[[2025,2,10]]}}}